OVID
Ovid Therapeutics Inc.Company with tickers: OVID
Market Cap
$475.93M
Shares Outstanding
186,640,102
CIK
1636651
CUSIP
690469101
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Anna Greka, M.D., Ph.D. | Class III director | Appointed | 2026-06-03 |